NJ Bio, Inc. is a CRO/CDMO specializing in integrated chemistry and biology services for ADCs and other complex bioconjugates. We offer comprehensive solutions spanning discovery, development, characterization, optimization, and bioanalysis, complemented by robust in vitro and in vivo capabilities to support translational decision-making. We provide toxicology, pharmacology, PK, and immunology services to support safety assessment, efficacy profiling, and translational development of ADC and bioconjugate programs. Our expertise in synthetic chemistry, bioconjugation, linker design, and bioanalytical capabilities, ensure seamless support across the entire drug development process and help accelerate ADC programs to become front-line treatments for cancer patients. | NJ Bio, Inc. is a CRO/CDMO that provides high-quality integrated chemistry and biology services to clients mostly from the biotech and pharma sectors. Main service areas include antibody-drug conjugates, bioconjugation, and multistep organic synthesis. The company is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania. NJ Bio’s facility in Princeton, NJ, occupies ~ 80,000 sq ft of laboratory and office space, with specialized laboratory suites for highly potent compound synthesis, bioconjugation, bioassays, and analytical studies. The facility is very well equipped with instrumentation required for ADC- and bioconjugation-related work. | NJ Bio, Inc. is a CRO/CDMO specializing in integrated chemistry and biology services for ADCs. We offer comprehensive solutions for ADC development, characterization, optimization, and bioanalysis. Our expertise in synthetic chemistry, bioconjugation, linker design, and bioanalytical capabilities, ensure seamless support across the entire drug development process and help accelerate ADC programs to become front-line treatments for cancer patients. | NJ Bio, Inc., is a CRO that provides high-quality integrated chemistry and biology services for ADCs, bioconjugates and nucleic acid-based therapeutics. We strive to be a beacon of excellence in contract research, development and manufacturing by providing cutting-edge biopharmaceutical and advanced chemistry services. Backed by deep expertise in bioconjugation & chemical synthesis, we add value to targeted therapeutic programs through integrated services in conjugation, process development, characterization, and bioanalysis of complex molecules.
Neuro-Sys
Neuro-Sys is a globally recognized, research-driven CRO specializing in advanced in vitro and in vivo models for neurodegenerative disease drug development. Our expertise in pharmacology and drug discovery allows us to offer unparalleled insights into compound mechanisms. Our studies empower clients to make informed decisions at every stage of drug development, building a cohesive narrative around compound efficacy and safety. Backed by a team of skilled neuropharmacologists, we are committed to delivering precise, reliable data through innovative technology and tailored research platforms. This commitment, combined with superior customer service, ensures efficiency and drives our clients’ success. | Neuro-Sys is a globally recognized, research-driven CRO specializing in advanced in vitro and in vivo models for neurodegenerative disease drug discovery. Our studies empower clients to make informed decisions at every stage of drug development, building a cohesive narrative around compound efficacy and safety. Backed by a team of experts, we are committed to delivering precise, reliable data through innovative technology and custom study designs. This commitment, combined with superior customer service, ensures efficiency and drives our clients’ success.
NanoTag Biotechnologies GmbH
Custom-tailored single-domain antibody solutions We provide high-quality single-domain antibodies (sdAbs) to advance research and biomedicine. From tailored sdAb discovery and innovative technologies to tools for immunofluorescence, super-resolution microscopy, and affinity purification, our solutions ensure reliability and precision. With custom-engineered nanobodies and protein production services, we empower you to tackle complex scientific challenges with confidence. Unlock the full potential of sdAbs with NanoTag Biotechnologies.
MediTox s. r. o.
MediTox s.r.o. is GLP-certified CRO dealing with preclinical R&D comprehensive preclinical and toxicological program for human/veterinary products (EMA, ICH/VICH, FDA), medical devices (ISO 10993), chemicals and agrochemicals (OECD TG), development of animal models of selected human diseases. Contract research activities are pointed to general toxicology and pharmacology (acute toxicity, long-term toxicity, immunogenicity, safety pharmacology, toxicokinetics, Proof-of-Concept), genetic toxicology (genotoxicity and mutagenicity in vitro and in vivo), biocompatibility of medical devices (local and systemic toxicity, implantation), safety assessment of vaccines, etc. The members of the toxicological team have experience with practically all species including NHP, dogs, ferrets, cats and pigs and various kinds of compounds and indications. Common and special ways of administration are available as well as GLP-compliant platform for bioanalyses, clinical pathology and histopathology. Undisputed advantages are an approval for handling GMO, experience with variety of compounds and therapeutic areas and in preclinical toxicology in non-rodent species, particularly in mini pig, ferret and dog models. C.I.R. accreditation was renewed for 2024 – 2026 OLAW (US National Institutes of Health) approval for 2020 – 2025 | MediTox s.r.o., a long established and fully GLP compliant, preclinical CRO, has been providing safety/efficacy evaluation for nearly 25 years: – non-clinical studies supporting phase I – III CT (exploratory & regulatory studies) – strong expertise in non-rodent toxicology – BEQ/BA/PK/TK studies – medical device (ISO 10993), small molecules, vaccines, biotech derived drugs, veterinary drugs, … (EMA/ICH/WICH/OECD/FDA) – influenza, chronic glaucoma, arthrosis, contact dermatitis models available – revision of study documentation (plan, data, report) MediTox s.r.o. provides specific services in multiples species, customized procedures, and tailored solutions. | x
Medicilon USA Corp
Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. From drug discovery, pharmaceutical research to preclinical research, Medicilon has supported more than 2000 client R&D programs worldwide resulting in 520 IND filings. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success. | Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. Medicilon has 21 years experience in the industry and has supported more than 2000 client R&D programs worldwide resulting in 580 IND filings. The company has over 441,320 ft2 of chemistry labs with > 1300 chemists located at three different sites. With operations in the USA, China, and Europe, Medicilon is a leading CRO offering integrated pharmaceutical R&D services, including DMPK/PD, toxicology (GLP and non-GLP), chemistry, discovery biology, and CMC research. In addition, Medicilon offers attractive large animal models (non-human primates, dogs, rabbits, and miniature pigs), tumor & non-tumor animal models (including Xenograft models, PDX / PDXO models), and support for simultaneous U.S. IND filing to streamline global drug development and approval.
JIANGSU YAOHAI BIO-PHARMACEUTICAL Co. ,Ltd
Yaohai Biopharmaceutical Co., Ltd. was founded in August 2010. It has served as a Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in microbial expression systems and offering one-stop services, including microbial strain engineering, microbial cell banking, process development, pilot scale-up, cGMP-guided manufacturing, fill and finish, analysis and testing, etc. Since its establishment, we have been focusing on “VLP vaccine, peptide, cytokine, nano-antibody, enzyme, plasmid DNA, mRNA, and others recombinant proteins or nucleic acids” as vaccines or therapeutics for human, veterinary, and pet health management. | Yaohai Bio-Pharma, founded in August 2010, is a specialized Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) offering end-to-end services based on microbial expression systems. Our integrated solutions span strain engineering, cell banking, process development, cGMP manufacturing, analytical testing, fill-finish, and regulatory support. We focus on recombinant protein/peptide, nano-body, mRNA, plasmid DNA, VLP vaccines and other modalities for both human and veterinary use. Core Strengths: 1. Comprehensive Service Platform: Covering the full development cycle—from preclinical to commercial production—under global regulatory standards (NMPA, FDA, EMA). 2. Advanced Manufacturing Capacity: 5 drug substance lines with a total microbial fermentation capacity of 7,500L (2L–2,000L), plus 2 drug product workshops for sterile fill-finish of vials (liquid/lyophilized powder) and pre-filled syringes/cartridges. 3. Scalable Solutions: Supporting rapid scale-up with GMP-compliant facilities and fermentors ranging from 2L to 2,000L. 4. Proven Expertise: A seasoned team with 15+ years of experience, delivering over 200 successful projects across diverse therapeutic areas.
ITR Laboratories Canada Inc
Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 30 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with over 400 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. ITR is committed to providing the highest quality services to suit the needs of sponsors; our expert staff will continue to stay up-to-date with the latest technological developments to ensure we are always ready for new and challenging projects. | Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. We also offer juvenile toxicology services. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 30 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with nearly 500 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. ITR is committed to providing the highest quality services to suit the needs of sponsors; our expert staff will continue to stay up-to-date with the latest technological developments to ensure we are always ready for new and challenging projects. | Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. We also offer juvenile toxicology services. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 35 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with over 500 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. Our most recent expansion was completed in February of 2023 and added an additional 8 animal rooms for a total of 80 rooms. Specializing in inhalation toxicology, ITR has 22 exposure rooms with over 750 completed inhalation studies, ITR is ranked as the #1 inhalation CRO in the world. ITR is committed to providing the highest quality services tailored to the needs of sponsors; our expert staff continues to stay up-to-date with the latest technological developments to ensure readiness for new and challenging projects.
Iris Biotech GmbH
Iris Biotech is providing high quality products for the fields peptide synthesis, linkerology, drug delivery, and life sciences in flexible quantities from research scale to commercial production, for academia as well as industry. Besides our broad portfolio from standard to exotic, we have the know-how and facilities to manufacture your compound of choice based on a Custom Synthesis. All our services are rounded off by a strong and competent personnel customer support. We are in continuous exchange with scientists all around the world to gather ideas and be ahead regarding technologies and innovations true to our slogan Empowering Peptide Innovation. | Founded in 2001, Iris Biotech provides scientists in both industry and academia with innovative and rare compounds, while also being your reliable partner for a comprehensive supply of standard consumables. Guided by our dedication to deliver competent service as well as the highest quality to our customers, our company’s focus remains Peptide Chemistry, while we also have strong expertise in Drug Delivery, Life Sciences, and Linkerology. Due to the growing demand for tailor-made compounds and solutions, we further increased our Custom Synthesis capabilities in 2013. Our skilled scientists and technicians offer profound expertise in the custom manufacturing of both simple and complex molecules. | Empowering Peptide Innovation With this guiding theme in mind, Iris Biotech’s mission is to support researchers by supplying • innovative technologies, • rare compounds, • as well as a broad portfolio on standard consumables, available in flexible quantities from small scale to bulk quantities. Guided by our dedication to provide • competent service, • as well as novel substances and • latest technologies, Iris Biotech is your trusted partner for the world of peptides, while having strong expertise in associated disciplines. Thus, our portfolio comprises reagents and tools for the synthesis and modification of peptides, e.g., amino acids, resins and solvents but also for related technologies such as drug delivery, linkerology® and life sciences. Your project requires a compound not listed in our portfolio? Get in contact and inquire about our custom synthesis capabilities. | Empowering Peptide Innovation – this is our guiding principle. Iris Biotech stands for innovation and know-how in the field of pharmaceuticals and biotechnology. With this guiding theme in mind, Iris Biotech attends various conferences, symposia and exhibitions each year, which allows us to remain in direct contact with scientists from academia and industry alike, in order to exchange knowledge, and to gather new ideas to tackle your current challenges. Our mission as qualified supplier and competent consultant is to support our customers in their ongoing projects from research scale to commercial production.